Alzheimer’s disease has long been a diagnosis that arrives only after memory begins to fray, by which time brain damage is already extensive. A new experimental drug called NU-9 is challenging that ...

A Cherokee County man living with Sickle Cell Disease is now the first known person with the condition to get a medical pilot’s license.

Explore 2025's groundbreaking scientific discoveries: the MoM-z14 galaxy, personalised CRISPR therapy, regenerative medicine, ...

Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of ...

An experimental gene therapy seems to slow the progression of Huntington’s disease by about 75 per cent, and researchers are ...

It was the best of times, it was the worst of times for research in 2025. | It was the best of times and it was the worst of times for research in 2025. Medical breakthroughs and stunning discoveries ...

Libtayo's approval for high-risk cutaneous squamous cell carcinoma offers a new immunotherapy option, targeting PD-1 ...

A push to reshore some drug production and progress in advanced manufacturing technologies have been prominent trends this year, industry leaders say.

CRISPR Therapeutics shares early autoimmune and lymphoma data for zugo-cel, showing strong responses, manageable safety, and expanded oncology plans.

Four autoimmune patients treated to date demonstrate deep B-cell depletion sustained for at least 28 days; initial efficacy ...

The region helped invent cell and gene therapy. Now, there’s an opportunity to reengineer it so more people can actually access it, a life sciences leader writes.

A small group of volunteers will receive multiple injections of the experimental treatments next month, says Unlimited Bio.